Showing results (1091-1100 of 1,132) with videos related to
Sort By:
Pageof 114
Asia-Pacific Journal of Clinical Oncology|October 2, 2018
The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailableL Chin-Lenn, R H De Boer, E Segelov, et al.The New England Journal of Medicine|December 6, 2023
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 DiabetesMichaela Waibel, John M Wentworth, Michelle So, et al.OTO Open|September 29, 2022
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2021Alexander M Choi, Michael J Brenner, Daniel Gorelik, et al.Circulation Research|March 17, 2026
Interleukin 11-Induced MicroRNAs as Functional Mediators and Circulating Biomarkers of Cardiac FibrosisRoman Tikhomirov, Veronika Boichenko, Benedict Reilly O'Donnell, et al.Nature Communications|October 1, 2016
Incipient ferroelectricity of water molecules confined to nano-channels of berylB P Gorshunov, V I Torgashev, E S Zhukova, et al.Circulation Research|October 23, 2020
Interaction of the Joining Region in Junctophilin-2 With the L-Type Ca2+ Channel Is Pivotal for Cardiac Dyad Assembly and Intracellular Ca2+ DynamicsPolina Gross, Jaslyn Johnson, Carlos M Romero, et al.BMJ Open|May 4, 2023
Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDAStephany Hiayev, Einat Shacham-Shmueli, Matitiahu Berkovitch, et al.Psychological Medicine|May 9, 2024
Alcohol milestones and internalizing, externalizing, and executive function: longitudinal and polygenic score associationsSarah E Paul, David A A Baranger, Emma C Johnson, et al.Pacing and Clinical Electrophysiology : PACE|November 9, 2019
Implantation of subcutaneous defibrillator is feasible and safe with monitored anesthesia careMuhammad R Afzal, Toshimasa Okabe, Tanner Koppert, et al.Blood|July 15, 2006
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myelomaPaul G Richardson, Emily Blood, Constantine S Mitsiades, et al.Pageof 114